Study finds wearable glucose monitors also benefit type 2 patients not using insulin

A study found that wearable glucose monitors—devices worn on the body to track blood sugar—also benefit people with type 2 diabetes who do not use insulin.^[1]

The finding supports use beyond insulin-treated patients, but the supplied report summary does not state the size of the benefit, the study population or the follow-up period, limiting assessment of its clinical significance.^[1]

For glucose-monitor makers such as Dexcom, evidence that more patients can benefit gives clinicians a reason to recommend devices to people not using insulin; if those recommendations turn into use, device demand could increase.^[1]

Clinical benefit does not automatically become revenue: patients still need to afford the devices or obtain insurance coverage. The supplied report describes no expansion in coverage, so the development strengthens the case for potential demand rather than confirming sales growth.^[1]

Impact

• Glucose-monitoring devicesOpportunity

  Dexcom and competing device makers gain additional clinical evidence for serving type 2 patients who do not use insulin. This broader customer base could generate demand if clinicians recommend the devices and patients can afford them; the study itself does not establish higher sales.^[1]